Best ADC Platform Technology
Winner – Fleximer (Mersana Therapeutics)
Runner Up – Bicycles (Bicycle Therapeutics)
Most Promising Clinical Candidate
Winner – Rovalpituzumab tesirine (Abbvie-Stemcentrx)
Runner Up – MEDI4276 (MedImmune)
Best Contract Manufacturing (CMO) Provider
Winner - BSP Pharmaceuticals
Runner Up - Piramal
Best Contract Research (CRO) Provider
Winner - Abzena
Best New Drug Developer sponsored by Pfizer
Winner - ADC Therapeutics
Runner Up – Mersana Therapeutics
Best Publication 2015
Winner - Saunders et al., A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. Sci Transl Med., 2015.
Runner Up - van Geel et al., Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody−Drug Conjugates; Bioconj. Chem., 2015.
Best Poster sponsored by Abbvie
Winner - Computational Exploration of Mechanistic Determinants of ADC Pharmacokinetics Using QSP Modeling Strategies; AK Wilkens et al.
Runner Up - Discovery and Characterization of ADCs with a Novel Mode of Action; G Piizzi et al.
Individual Input to the Field 2015/2016
Winner - David Thurston
Runner Up - Scott Dylla
Long Standing Contribution
Winner - John Lambert